Výsledky vyhledávání - "U.F.F. De Giorgi"

216MO A randomized phase II trial of metronomic oral vinorelbine plus cyclophosphamide and capecitabine (VEX) vs weekly paclitaxel (P) as first- or second-line treatment in patients (pts) with ER+/HER2- metastatic breast cancer (MBC): The METEORA-II trial (IBCSG 54-16)

Autor: E. Munzone, M.M. Regan, S. Cinieri, E. Montagna, L. Orlando, R. Shi, E. Campadelli, L. Gianni, U.F.F. De Giorgi, C. Bengala, D. Generali, E. Collova, F. Puglisi, E. Cretella, C. Zamagni, C. Chini, A. Goldhirsch, M.A. Colleoni

Publikováno v: Annals of Oncology. 33:S636-S637

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df3b66ac50cad424fcb20aa8c9edd1f9
https://doi.org/10.1016/j.annonc.2022.07.255

Zobrazit plný text záznamu

1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)

Autor: M. Stellato, S. Buti, M. Maruzzo, M. Bersanelli, P. Ermacora, B.A. Maiorano, V. Prati, U.F.F. De Giorgi, F. Pierantoni, A. Malgeri, A. Mennitto, A. Cavo, M.G. Vitale, M. Santoni, C. Carella, G. Procopio, E. Verzoni, D. Santini

Publikováno v: Annals of Oncology. 33:S1214-S1215

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0016ab9270369c5cadecbdf7f029d286
https://doi.org/10.1016/j.annonc.2022.07.1565

Zobrazit plný text záznamu

1449MO Updated efficacy of lenvatinib (LEN) + pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study

Autor: C.G. Porta, M. Eto, R.J. Motzer, U.F.F. De Giorgi, T. Buchler, N.S. Basappa, M.J. Mendez Vidal, S. Tjulandin, S.H. Park, B. Melichar, T.E. Hutson, C. Alemany, B. McGregor, C.S. He, R. Perini, K. Mody, J. McKenzie, T.K. Choueiri

Publikováno v: Annals of Oncology. 33:S1205-S1206

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f5925522245f83d9e05815c9c755d57
https://doi.org/10.1016/j.annonc.2022.07.1552

Zobrazit plný text záznamu

23P Pre-treatment inflammatory indexes predict the clinical outcome of patients with endometrial cancer: A MITO24 study

Autor: A. Farolfi, E. Scarpi, V. Loizzi, R. Cioffi, V. Tuninetti, G. Valabrega, C. Godina, C. Casanova, J. Ventriglia, F. Arezzo, S. Pignata, G. Candotti, G. Cormio, U.F.F. De Giorgi

Publikováno v: ESMO Open. 8:100794

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c2aea128817c454b0d5b4b274bfe3d6
https://doi.org/10.1016/j.esmoop.2023.100794

Zobrazit plný text záznamu

53P Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients

Autor: A. Farolfi, E. Petracci, G. Gurioli, G. Tedaldi, C. Casanova, V. Arcangeli, M. Rosati, S.L. Burgio, M.C. Cursano, C. Lolli, G. Schepisi, U.F.F. De Giorgi

Publikováno v: ESMO Open. 8:100833

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a21f62cc958c11bd33f62a27782ad450
https://doi.org/10.1016/j.esmoop.2023.100833

Zobrazit plný text záznamu

50P Direct-acting oral anticoagulants prescribing pattern in patients with gynaecological cancer: Results of a survey among Italian oncologists belonging to MITO group and AIOM society

Autor: V. Tuninetti, A. Milani, S. Pignata, D. Lorusso, D. Castaldo, U.F.F. De Giorgi, A. Savarese, N. Biglia, G. Scandurra, S. Testa, G. Mangili, M. Di Maio, M. Turinetto, S. Mammoliti, G. Scotto, G. Artioli, G. Valabrega

Publikováno v: Annals of Oncology. 33:S403

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef1b64eb98539e57459eebe771b0ba7b
https://doi.org/10.1016/j.annonc.2022.04.067

Zobrazit plný text záznamu